Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
McDermott announces confirmation of plan of reorganization » 15:25
03/12/20
03/12
15:25
03/12/20
15:25
MDR

McDermott

$0.00 /

+ (+0.00%)

McDermott International…

McDermott International announced that the U.S. Bankruptcy Court for the Southern District of Texas has confirmed the company's plan of reorganization and approved the sale of Lummus Technology to a joint partnership between The Chatterjee Group and Rhone Capital. Under the terms of the Plan, McDermott will complete a comprehensive restructuring transaction to de-lever its balance sheet and immediately position the company for long-term growth. The transaction will allow the company to emerge with more cash on hand than debt, eliminating over $4.6B of debt. The company expects to emerge in the second quarter following the receipt of regulatory approval for the sale of Lummus Technology to the joint partnership. As announced on January 21, 2020, subsidiaries of McDermott entered into a share and asset purchase agreement to sell Lummus Technology to the joint partnership, as the "stalking horse bidder," for a base purchase price of $2.725B, subject to higher or otherwise better bids received through a court-supervised auction process. Proceeds from the sale of Lummus Technology are expected to repay McDermott's DIP financing in full, as well as fund emergence costs and provide cash to the balance sheet for long-term liquidity.

ShowHide Related Items >><<
MDR McDermott
$0.00 /

+ (+0.00%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
Hot Stocks
Tanger Factory to replace McDermott in S&P 600 at open on 1/27 » 04:55
01/27/20
01/27
04:55
01/27/20
04:55
SKT

Tanger Factory

$15.55 /

-0.835 (-5.10%)

, MDR

McDermott

$0.00 /

+ (+0.00%)

McDermott International…

McDermott International announced it will file to reorganize under Chapter 11 of the U.S. Bankruptcy Code.

ShowHide Related Items >><<
SKT Tanger Factory
$15.55 /

-0.835 (-5.10%)

05/09/19 Goldman Sachs
Tanger Factory downgraded to Sell from Neutral at Goldman Sachs
03/25/19 Boenning & Scattergood
Tanger Factory initiated with an Outperform at Boenning & Scattergood
MDR McDermott
$0.00 /

+ (+0.00%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
Options
Ten new option listings and two option delistings on January 23rd » 08:30
01/23/20
01/23
08:30
01/23/20
08:30
AKRO

Akero Therapeutics

$23.34 /

+0.46 (+2.01%)

, AQST

Aquestive Therapeutics

$3.90 /

-0.2 (-4.88%)

, CYCN

Cyclerion Therapeutics

$3.75 /

+0.23 (+6.53%)

, ITRN

Ituran

$25.31 /

-0.51 (-1.98%)

, OBSV

ObsEva

$4.39 /

-0.09 (-2.01%)

, PHAS

PhaseBio

$5.43 /

-0.2 (-3.55%)

, PHAT

Phathom Pharmaceuticals

$38.10 /

+1.29 (+3.50%)

, STOK

Stoke Therapeutics

$23.87 /

+0.52 (+2.23%)

, XP

XP Inc.

$42.45 /

+1.845 (+4.54%)

, MDR

McDermott

$0.70 /

+ (+0.00%)

, TOO

Changed to ALIN

$1.54 /

-0.005 (-0.32%)

New option listings for…

New option listings for January 23rd include Akero Therapeutics Inc (AKRO), Aquestive Therapeutics Inc (AQST), Cyclerion Therapeutics Inc (CYCN), Ituran (ITRN), McDermott International Inc (MDRIQ), ObsEva (OBSV), PhaseBio Pharmaceuticals Inc (PHAS), Phathom Pharmaceuticals Inc (PHAT), Stoke Therapeutics Inc (STOK), and XP Inc (Class A Stock) (XP). Option delistings effective January 23rd include McDermott International Inc (MDR) and Teekay Offshore Partners LP (Units) (TOO).

ShowHide Related Items >><<
AKRO Akero Therapeutics
$23.34 /

+0.46 (+2.01%)

07/15/19 Evercore ISI
Akero Therapeutics initiated with an Outperform at Evercore ISI
07/15/19 Jefferies
Akero Therapeutics initiated with a Buy at Jefferies
07/15/19 JPMorgan
Akero Therapeutics initiated with an Overweight at JPMorgan
07/15/19 Roth Capital
Akero Therapeutics initiated with a Buy at Roth Capital
AQST Aquestive Therapeutics
$3.90 /

-0.2 (-4.88%)

01/13/20 Lake Street
Aquestive competitor approval may bring overhang, says Lake Street
12/27/19 Lake Street
Aquestive Therapeutics price target lowered to $10 from $11 at Lake Street
12/17/19 Wedbush
Aquestive Therapeutics price target lowered to $34 from $37 at Wedbush
12/02/19 JMP Securities
Aquestive Therapeutics NDA filing a positive sign, says JMP Securities
CYCN Cyclerion Therapeutics
$3.75 /

+0.23 (+6.53%)

08/21/19 Spin-Off Research
Cyclerion Therapeutics upgraded to Buy from Hold at Spin-Off Research
06/03/19 Credit Suisse
Cyclerion Therapeutics initiated with a Neutral at Credit Suisse
ITRN Ituran
$25.31 /

-0.51 (-1.98%)

05/16/19 Barclays
Ituran initiated with an Overweight at Barclays
OBSV ObsEva
$4.39 /

-0.09 (-2.01%)

12/19/19 H.C. Wainwright
ObsEva price target raised to $40 from $36 at H.C. Wainwright
12/02/19 H.C. Wainwright
ObsEva price target lowered to $36 from $44 at H.C. Wainwright
11/08/19 Credit Suisse
ObsEva downgraded to Neutral from Outperform at Credit Suisse
07/29/19 Credit Suisse
ObsEva price target lowered to $16 from $24 at Credit Suisse
PHAS PhaseBio
$5.43 /

-0.2 (-3.55%)

01/16/20 Stifel
PhaseBio acquisition of PB6440 an 'excellent' strategic move, says Stifel
12/18/19 Citi
Citi calls PhaseBio most undervalued SMid-Biotech stock
10/03/19 H.C. Wainwright
PhaseBio initiated with a Buy at H.C. Wainwright
09/09/19 Stifel
PhaseBio selloff on prasugrel vs. ticagrelor study 'well overdone,' says Stifel
PHAT Phathom Pharmaceuticals
$38.10 /

+1.29 (+3.50%)

11/19/19 Evercore ISI
Phathom Pharmaceuticals initiated with an Outperform at Evercore ISI
11/19/19
Fly Intel: Top five analyst initiations
11/19/19 Needham
Phathom Pharmaceuticals initiated with a Buy at Needham
11/19/19 Jefferies
Phathom Pharmaceuticals initiated with a Buy at Jefferies
STOK Stoke Therapeutics
$23.87 /

+0.52 (+2.23%)

12/17/19 Wedbush
Stoke Therapeutics initiated with an Outperform at Wedbush
11/12/19
Fly Intel: Top five analyst initiations
11/12/19 BTIG
Stoke Therapeutics initiated with a Buy at BTIG
10/25/19 H.C. Wainwright
Stoke Therapeutics initiated with a Buy at H.C. Wainwright
XP XP Inc.
$42.45 /

+1.845 (+4.54%)

01/06/20 Morgan Stanley
Morgan Stanley starts XP Inc. at Overweight with $45 price target
01/06/20 Morgan Stanley
XP Inc. initiated with an Overweight at Morgan Stanley
01/06/20 JPMorgan
XP Inc. initiated with an Overweight at JPMorgan
01/05/20 Goldman Sachs
XP Inc. initiated with a Neutral at Goldman Sachs
MDR McDermott
$0.70 /

+ (+0.00%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
TOO Changed to ALIN
$1.54 /

-0.005 (-0.32%)

Hot Stocks
Tanger Factory to replace McDermott in S&P 600 at open on 1/27 » 17:18
01/21/20
01/21
17:18
01/21/20
17:18
SKT

Tanger Factory

$15.93 /

+0.56 (+3.64%)

, MDR

McDermott

$0.70 /

+ (+0.00%)

McDermott International…

McDermott International announced it will file to reorganize under Chapter 11 of the U.S. Bankruptcy Code.

ShowHide Related Items >><<
SKT Tanger Factory
$15.93 /

+0.56 (+3.64%)

05/09/19 Goldman Sachs
Tanger Factory downgraded to Sell from Neutral at Goldman Sachs
03/25/19 Boenning & Scattergood
Tanger Factory initiated with an Outperform at Boenning & Scattergood
MDR McDermott
$0.70 /

+ (+0.00%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
Hot Stocks
Fly Intel: Pre-market Movers » 09:17
01/21/20
01/21
09:17
01/21/20
09:17
ARAY

Accuray

$3.27 /

-0.16 (-4.66%)

, HAL

Halliburton

$23.96 /

+0.15 (+0.63%)

, UBS

UBS

$13.13 /

-0.06 (-0.45%)

, TAL

TAL Education

$54.07 /

-2 (-3.57%)

, MDR

McDermott

$0.70 /

-0.0224 (-3.12%)

, ORGS

Orgenesis

$5.40 /

+0.36 (+7.14%)

, LVS

Las Vegas Sands

$74.07 /

+0.67 (+0.91%)

, LL

Lumber Liquidators

$9.35 /

+0.06 (+0.65%)

HIGHER: Accuray (ARAY),…

HIGHER: Accuray (ARAY), up 10% after BTIG analyst Marie Thibault upgraded shares to Buy from Neutral with a $9.50 price target. The analyst notes that the company's long-term revenue growth outlook of 8%-12% announced last week, driven in large part by the contribution from China, is "significantly higher" than its historical performance and the low-to-single digit growth anticipated by consensus. UP AFTER EARNINGS: Halliburton (HAL), up 1%. DOWN AFTER EARNINGS: UBS (UBS), down 4%... TAL Education (TAL), down 8%. ALSO LOWER: McDermott (MDR), down 14% after announcing that it has the support of more than two-thirds of all its funded debt creditors for a restructuring transaction that will equitize nearly all the company's funded debt, eliminating over $4.6B of debt. The restructuring transaction will be implemented through a prepackaged Chapter 11 process that will be financed by a debtor-in-possession financing facility of $2.81B... Las Vegas Sands (LVS), down 5% after Morgan Stanley analyst Thomas Allen downgraded the stock to Equal Weight from Overweight. He continues to see the stock as "the mass market play on Macau" and his Macau mass market growth forecast for 2020 trails what Consensus Metrix suggests is the U.S. analyst forecast average... Orgenesis (ORGS), down 7% after announcing it has entered into a definitive securities purchase agreement for the sale of 2,200,000 shares of the company's common stock in a private placement at a purchase price of $4.20 per share and warrants to purchase up to 1,000,000 shares of common stock at an exercise price of $5.50 per share... Lumber Liquidators (LL), down 6% after Morgan Stanley analyst Simeon Gutman downgraded shares to Underweight from Equal Weight with a price target of $5, down from $9.

ShowHide Related Items >><<
ARAY Accuray
$3.27 /

-0.16 (-4.66%)

01/21/20 BTIG
Accuray upgraded to Buy from Neutral at BTIG
12/11/19 Lake Street
Accuray shares have two imminent catalysts, says Lake Street
09/16/19
Accuray to host investor meeting
01/29/19 Lake Street
Lake Street encourages investors to revisit Accuray shares
HAL Halliburton
$23.96 /

+0.15 (+0.63%)

01/13/20 Bernstein
Bernstein initiates coverage of Global Oil Services sector
01/13/20 Bernstein
Halliburton initiated with an Underperform at Bernstein
01/06/20 Scotiabank
Scotiabank rearranges U.S. Oilfield Services ratings with eight changes
01/06/20 Scotiabank
Halliburton upgraded to Outperform from Sector Perform at Scotiabank
UBS UBS
$13.13 /

-0.06 (-0.45%)

10/22/19 Evercore ISI
Waddell & Reed downgraded at Evercore ISI after UBS announces new initiative
10/22/19 Evercore ISI
UBS initiative to pressure retail asset managers like Invesco, says Evercore ISI
09/10/19 Kepler Cheuvreux
UBS upgraded to Buy from Hold at Kepler Cheuvreux
08/30/19
Fly Intel: Top analyst downgrade
TAL TAL Education
$54.07 /

-2 (-3.57%)

01/16/20 TH Data Capital
New Oriental Education price target raised to $160 from $130 at TH Data Capital
01/09/20 Macquarie
TAL Education upgraded to Outperform from Neutral at Macquarie
01/08/20 Macquarie
TAL Education upgraded to Outperform from Neutral at Macquarie
11/01/19
Fly Intel: Top five analyst upgrades
MDR McDermott
$0.70 /

-0.0224 (-3.12%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
ORGS Orgenesis
$5.40 /

+0.36 (+7.14%)

09/26/19 Benchmark
Orgenesis initiated with a Speculative Buy at Benchmark
LVS Las Vegas Sands
$74.07 /

+0.67 (+0.91%)

01/21/20 Morgan Stanley
Las Vegas Sands downgraded to Equal Weight from Overweight at Morgan Stanley
01/16/20 Standpoint Research
Las Vegas Sands downgraded to Hold from Buy at Standpoint Research
01/13/20 Goldman Sachs
Wynn Resorts upgraded to Conviction Buy from Buy at Goldman Sachs
01/08/20 Stifel
Eldorado Resorts named top Gaming & Leisure idea for 2020 at Stifel
LL Lumber Liquidators
$9.35 /

+0.06 (+0.65%)

01/21/20 Morgan Stanley
Lumber Liquidators downgraded to Underweight from Equal Weight at Morgan Stanley
12/04/19 Wedbush
Floor & Decor to see earnings boost from tariff exclusion, says Wedbush
09/13/19 Raymond James
Lumber Liquidators price target raised to $14 from $10 at Raymond James
06/05/19 Raymond James
Tariffs creating new 'headaches' for Lumber Liquidators, says Raymond James
Hot Stocks
McDermott files for Chapter 11 bankruptcy » 07:59
01/21/20
01/21
07:59
01/21/20
07:59
MDR

McDermott

$0.70 /

-0.0224 (-3.12%)

McDermott announced that…

McDermott announced that it has the support of more than two-thirds of all its funded debt creditors for a restructuring transaction that will equitize nearly all the company's funded debt, eliminating over $4.6B of debt. The restructuring transaction will be implemented through a prepackaged Chapter 11 process that will be financed by a debtor-in-possession financing facility of $2.81B. Subject to court approval, McDermott expects the DIP financing, combined with cash generated by McDermott, to enable the company to stabilize its cash flows, continue operating in the normal course and fulfill its commitments to key stakeholders, including customers, suppliers, joint-venture partners, business partners and employees. The company also has secured committed exit financing of over $2.4B in letter of credit facility capacity and will emerge from Chapter 11 with approximately $500M in funded debt. The restructuring transaction will strengthen the company's balance sheet, normalize its trade debt and position the company for long-term growth. All of McDermott's businesses are expected to continue to operate as normal for the duration of the restructuring. McDermott expects to continue to pay employee wages and health and welfare benefits, and to pay all suppliers in full. All customer projects are expected to continue uninterrupted on a global basis. This morning, the company commenced solicitation of votes from its lenders and bondholders in support of a prepackaged Chapter 11 Plan of Reorganization. The company intends to commence the prepackaged Chapter 11 filing in the U.S. Bankruptcy Court for the Southern District of Texas later today. The company's support from all of its creditor constituencies is memorialized in a Restructuring Support Agreement. The company plans to move swiftly toward Court approval of the Plan, with confirmation expected within approximately two months from filing. As part of the restructuring transaction, subsidiaries of McDermott have entered into a share and asset purchase agreement with a joint partnership between The Chatterjee Group and Rhone Group pursuant to which the Joint Partnership will serve as the "stalking-horse bidder" in a court-supervised sale process for Lummus Technology. Under the terms of the Agreement, the Joint Partnership has agreed, and is committed, to acquire Lummus Technology for a base purchase price of $2.725B. McDermott will have the option to retain or purchase, as applicable, a 10% common equity ownership interest in the entity purchasing Lummus Technology. McDermott expects to hold an auction in approximately 45 days to solicit higher or better bids for the Lummus Technology business. Either the Joint Partnership or the winning bidder at the auction will purchase Lummus Technology as part of the Chapter 11 process, subject to regulatory and court approval. Proceeds from the sale of Lummus Technology are expected to repay the DIP financing in full, as well as fund emergence costs and provide cash to the balance sheet for long-term liquidity. As a result of the upcoming Chapter 11 filing, McDermott expects to be delisted from the New York Stock Exchange within the next 10 days. McDermott common stock will continue to trade in the over-the-counter marketplace throughout the pendency of the Chapter 11 process. The shares are proposed to be cancelled as part of McDermott's restructuring.

ShowHide Related Items >><<
MDR McDermott
$0.70 /

-0.0224 (-3.12%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
Hot Stocks
McDermott files for Chapter 11 bankruptcy  07:55
01/21/20
01/21
07:55
01/21/20
07:55
MDR

McDermott

$0.70 /

-0.0224 (-3.12%)

 
ShowHide Related Items >><<
MDR McDermott
$0.70 /

-0.0224 (-3.12%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
Hot Stocks
McDermott trading halted, news pending  07:46
01/21/20
01/21
07:46
01/21/20
07:46
MDR

McDermott

$0.70 /

-0.0224 (-3.12%)

 
ShowHide Related Items >><<
MDR McDermott
$0.70 /

-0.0224 (-3.12%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
Hot Stocks
McDermott announces start of commercial operation of Freeport LNG Train 2 » 13:02
01/17/20
01/17
13:02
01/17/20
13:02
MDR

McDermott

$0.73 /

+0.0119 (+1.66%)

McDermott International,…

McDermott International, with its partners, Chiyoda International Corporation and Zachry Group, announced the beginning of commercial operation of Train 2 of the Freeport LNG project, owned by Freeport LNG Development, L.P. Freeport LNG Train 3 remains on track to meet its previously announced schedule, with initial production of LNG scheduled for Q1 of 2020, the company said. "We continue to advance the Freeport LNG Project with another significant accomplishment, the commercial operation of Train 2. Congratulations to the joint venture project team who has maintained a commitment to safety and quality. Now we turn our full attention to delivery of the final train," added Mark Coscio, McDermott's Senior Vice President for North, Central and South America.

ShowHide Related Items >><<
MDR McDermott
$0.73 /

+0.0119 (+1.66%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott
Hot Stocks
McDermott enters agreement for lenders to hold off on declaring default » 15:53
01/15/20
01/15
15:53
01/15/20
15:53
MDR

McDermott

$0.77 /

+0.0749 (+10.75%)

McDermott International…

McDermott International said earlier in a regulatory filing that it entered into a credit agreement amendment that amends the events of default to provide that, through January 21, 2020, the acceleration of MTA's and MTUS' 10.625% Senior Notes due 2024 will not constitute an event of default; and amends the credit agreement to allow ordinary course auto-renewals of letters of credit despite any acceleration, bankruptcy, or other event of default. At 11:59 p.m. New York City time on January 15, 2020, the forbearance deadline under an agreement, dated December 1, 2019, by and among McDermott, MTA, MTUS, certain subsidiaries of McDermott and an ad hoc group of holders of approximately 35% of MTA's and MTUS' 10.625% Senior Notes due 2024 will expire. "Despite the expiration of the forbearance deadline, McDermott continues to engage in constructive conversations with holders of the Senior Notes," the filing stated.

ShowHide Related Items >><<
MDR McDermott
$0.77 /

+0.0749 (+10.75%)

01/13/20 Bernstein
McDermott initiated with an Underperform at Bernstein
11/05/19 Citi
McDermott bankruptcy risk is rising, Citi says, while cutting target to $1.60
09/20/19 Credit Suisse
McDermott's plans to sell Lummus 'a last resort,' says Credit Suisse
09/19/19 Citi
Citi sees working capital unwind as 'legitimate risk' for McDermott

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.